Werewolf Therapeutics's market cap is currently $61.50M. The company's EPS TTM is $-1.495; its P/E ratio is ―; Werewolf Therapeutics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 19.94M	$ 16.40M	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -18.96M	$ 13.89M	$ -735.00K	$ -777.00K	$ -463.00K
Operating Income	$ -40.50M	$ -56.06M	$ -50.09M	$ -22.40M	$ -9.94M
EBITDA	$ -32.47M	$ -51.30M	$ -49.25M	$ -14.26M	$ -9.41M
Net Income	$ -37.37M	$ -51.56M	$ -49.77M	$ -14.94M	$ -10.99M
Balance Sheet
Cash & Short-Term Investments	$ 134.34M	$ 129.31M	$ 157.53M	$ 92.57M	$ 17.90M
Total Assets	$ 174.83M	$ 160.25M	$ 179.25M	$ 96.40M	$ 21.68M
Total Debt	$ 51.92M	$ 14.68M	$ 15.66M	$ 2.54M	$ 3.14M
Net Debt	$ -82.42M	$ -114.63M	$ -141.87M	$ -90.03M	$ -14.76M
Total Liabilities	$ 63.46M	$ 37.91M	$ 26.46M	$ 148.26M	$ 45.98M
Stockholders' Equity	$ 111.37M	$ 122.34M	$ 152.79M	$ -51.86M	$ -24.30M
Cash Flow
Free Cash Flow	$ -33.38M	$ -44.21M	$ -43.37M	$ -19.18M	$ -9.81M
Operating Cash Flow	$ -32.61M	$ -40.60M	$ -42.88M	$ -18.62M	$ -9.54M
Investing Cash Flow	$ -769.00K	$ -3.61M	$ -498.00K	$ -560.00K	$ -266.00K
Financing Cash Flow	$ 58.43M	$ 15.91M	$ 109.43M	$ 93.86M	$ 21.91M

Currency in USD

Werewolf Therapeutics Earnings and Revenue History

Income Statement >

Werewolf Therapeutics Debt to Assets

Balance Sheet >

Werewolf Therapeutics Cash Flow

Cash Flow >

Werewolf Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing